SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.139+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Redman1234 who wrote (856)1/30/2025 4:48:16 PM
From: immucrazy6 Recommendations

Recommended By
bobbseytwins2001
erippetoe
Fitzhughlaw
jargonweary
rodneyh07

and 1 more member

   of 1230
 
I am not sure I understand why the company seems to have purposely not disclosed the terms of the collaboration? I would have assumed it must be for more than splitting costs for the NSLC trials, but the lack of financial details leads me to believe (cynically) that PSS shall dilute us once again! I am overweight on this biotech - I have been buying for the past 16 months, or so, and have my wife worried that my enthusiasm might lead to another disaster like CLVS (screwed by mismanagement and likely fraud). I felt like the science was compelling, so compelling I lost 300K!! It is sometimes hard to walk away when you know you should.

Also, I am thrilled to see so many from the IMMU days now communicating about IBRX...Twenty years of engaging with many of you vis a vis IMMU discussions, you kind of miss those times of group therapy to withstand the idiocy of Dr G and Cindy. Again, so great to view so many familiar names...

Signed: Immucrazy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext